HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.

Clinical trial NCT07233070 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07233070
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2025-10-31
Primary completion: 2026-10-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.